On a December call as part of the 39th annual J.P. Morgan Healthcare Conference, Medtronic CEO Geoff Martha shared insights on the company's robotic and spine strategies for the future.
Spinal Tech
Full-year 2020 revenue for SeaSpine declined 3 percent year over year to between $154.1 million and $154.5 million, according to a preliminary unaudited report released Jan. 11.
The FDA granted clearance of 40 orthopedic and spine devices in December.
Pacira Biosciences reported a record revenue of $429.6 million last year, according to a Jan. 7 news release.
From two big-money acquisitions in the orthopedic space to a new CEO entering the fray, here is the latest device company news:
Advertisement
Full-year 2020 revenue for SI-Bone, a sacropelvic device company, increased 9 percent to between $73.1 million and $73.4 million year over year, according to a preliminary unaudited report on Jan. 7.
Laura Francis, SI-Bone's CFO and COO, has been unveiled as the next CEO of the sacropelvic device company.
Parvizi Surgical Innovation, a company owned by orthopedic surgeon Javad Parvizi, MD, has invested in a software company focused on medical grade virtual reality and augmented reality technology for surgical training.
Arthrodesis, a company owned by Rama Chandran, MD, is suing Wright Medical for patent infringement.
NuVasive's stock rose 5.8 percent Jan. 6 after publication of its study regarding single-position spine surgery in The Spine Journal, according to Seeking Alpha.